Sonia Segura

6PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingAllergyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2026
Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series.

|Feb 03, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'.

Michela Starace, Luca Rapparini, Stephano Cedirian

|May 23, 2024
SDRIFE and bullous reaction after treatment with enfortumab vedotin plus pembrolizumab: Case series.

Juan J Lluch-Galcerá, Nerea Manzanares-Oliver, Manel Martinez-Molina

|Jul 29, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.

Pietro Sollena, Nikolaou Vasiliki, Elias Kotteas

|Feb 02, 2023
Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway.

Evelyn Andrades, Agustí Toll, Gustavo Deza

|May 26, 2018
Cutaneous toxicities of new treatments for melanoma.

A Boada, C Carrera, S Segura

Pageof 1

Frequent Collaborators

2 joint publications

Cristina Carrera

2 joint publications

Azael Freites-Martinez

2 joint publications

Julia Riganti

2 joint publications

Ane Jaka